Type 1 Diabetes Mellitus Clinical Trials

76 recruiting

Type 1 Diabetes Mellitus Trials at a Glance

74 actively recruiting trials for type 1 diabetes mellitus are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 23 trials, with the heaviest enrollment activity in Aurora, Seattle, and Boston. Lead sponsors running type 1 diabetes mellitus studies include Rodolfo Alejandro, Sanofi, and Princess Margaret Hospital.

Browse type 1 diabetes mellitus trials by phase

Treatments under study

About Type 1 Diabetes Mellitus Clinical Trials

Looking for clinical trials for Type 1 Diabetes Mellitus? There are currently 76 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Type 1 Diabetes Mellitus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Type 1 Diabetes Mellitus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 74 trials

Recruiting
Phase 2

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia
Zucara Therapeutics Inc.186 enrolled46 locationsNCT05762107
Recruiting
Phase 3

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi723 enrolled141 locationsNCT07088068
Recruiting
Phase 2Phase 3

Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus
Nanjing Medical University96 enrolled1 locationNCT07548996
Recruiting
Phase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Type 1 Diabetes Mellitus
Mannkind Corporation100 enrolled10 locationsNCT07224321
Recruiting
Not Applicable

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Hoffmann-La Roche270 enrolled16 locationsNCT06704672
Recruiting
Phase 2

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
Phase 2

An Adaptive Design Study of MTX228

Type 1 Diabetes Mellitus
University of Alberta24 enrolled1 locationNCT06474598
Recruiting
Phase 1

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Type 1 Diabetes MellitusType 1 Diabetes (T1D)
GentiBio, Inc16 enrolled10 locationsNCT06919354
Recruiting
Early Phase 1

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital9 enrolled1 locationNCT07528105
Recruiting
Phase 2

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi10 enrolled11 locationsNCT06791291
Recruiting
Not Applicable

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Type 1 Diabetes Mellitus
i-SENS, Inc.32 enrolled4 locationsNCT07296276
Recruiting

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

Type 1 Diabetes MellitusLatent Autoimmune Diabetes in Adult (LADA)
Fondazione IRCCS Policlinico San Matteo di Pavia75 enrolled1 locationNCT07434154
Recruiting
Phase 2

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)66 enrolled3 locationsNCT07142252
Recruiting
Not Applicable

Feasibility of a Tailored Online Self-compassion Intervention

Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus
Canterbury Christ Church University50 enrolled2 locationsNCT07051005
Recruiting

Long Term Follow up of Recipients of Functional Islet Allografts

Type 1 Diabetes Mellitus
Rodolfo Alejandro30 enrolled1 locationNCT01999374
Recruiting

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

Type 1 Diabetes Mellitus
Rodolfo Alejandro60 enrolled1 locationNCT02000687
Recruiting
Not Applicable

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

Type 1 Diabetes Mellitus
Rodolfo Alejandro18 enrolled1 locationNCT01999361
Recruiting

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Type 1 Diabetes MellitusDiabetic Ketoacidosis
Aristotle University Of Thessaloniki45 enrolled1 locationNCT07483879
Recruiting
Not Applicable

Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

Type 1 Diabetes Mellitus
Jane Yardley30 enrolled1 locationNCT06686329
Recruiting

Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes

Type 1 Diabetes Mellitus
Peking University First Hospital340 enrolled1 locationNCT07468474